• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » ACC issues ‘urgent’ message, but to whom?

ACC issues ‘urgent’ message, but to whom?

April 28, 2015 By MassDevice Contributors Network

By Westby G. Fisher, MD, FACC

Westby Fisher

The American College of Cardiology (ACC) leadership, troubled by the “complex situation” presented by the changes in re-certification by the American Board of Internal Medicine (ABIM), issued an “urgent message” yesterday on their blog.

This message hinted at the ACC’s pathway forward: to create a “second task force” to “aggressively” explore “whether an alternative board should/could be developed by ACC for our members.” They then add a cautionary note, stating “while working as rapidly as possible, we want to be cautious, realizing the great complexity of the situation.”

So what are cardiologists and cardiac electrophysiologists to think of this latest “urgent message?”

It is clear that the ABIM’s MOC program as it exists can no longer be considered legitimate. However, the ripple effects of the scandal of the ABIM and its Foundation are so far reaching that every single member board of the American Board of Medical Specialties’ MOC constructs’ twenty-four member boards will open themselves to scrutiny once the financial genie leaves the bottle. It is not easy to unravel a monopoly when it’s found to be (1) scientifically unfounded, (2) corrupt, and (3) profitable to the many leaders of these unaccountable non-profit organizations’ leadership.

The era of the gilded age of non-profit organizations controlling medicine is coming to an end and every one of the scientific non-profit organizations that have hid behind their secretive walls for so long know it.

That’s why this message was so “urgent.”

-Wes

Filed Under: Blog, Healthcare Reform, Hospital Care, News Well Tagged With: Dr. Wes, Insurance

More recent news

  • Data backs DermaSensor skin cancer detection device
  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy